How to better understand ophthalmic drug shortage impacts, with Ian Pitha, MD, PhDByIan Pitha, MD, MS,Kevin KunzmannMarch 19th 2026
Ophthalmic drug shortages are 'eroding' patient trust, with Ian Pitha, MD, PhDByIan Pitha, MD, MS,Kevin KunzmannMarch 12th 2026
Aerie Pharmaceuticals CEO discusses what's new in the pipelineByDavid Hutton,OT Staff ReportsMarch 22nd 2022
ImprimisRx offers a look at three new products in the pipeline ByDavid Hutton,Alex Delaney-Gesing November 14th 2021
Making the grade: FDA approves first biosimilar product for retinal diseasesByLynda ChartersNovember 1st 2021